CG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Carlyle Group is not a strong buy right now for a Beginner investor with a long-term focus, despite decent fundamentals. The stock has good earnings growth and supportive operating news, but the current technical setup is only neutral, analyst opinion is mixed-to-neutral, and the recent price action is weak. For an impatient buyer, this is more of a hold than an immediate buy.
CG closed at 49.06, slightly above the prior close, but the regular session was down 3.52%, showing clear recent weakness. RSI_6 at 42.54 is neutral and below momentum strength levels. MACD histogram is positive at 0.0425 but contracting, which suggests upside momentum is fading. Moving averages are converging, so the trend is indecisive rather than strongly bullish. Key levels: Pivot 49.59, resistance 51.97 and 53.44, support 47.22 and 45.75. The stock is sitting near pivot/support without a strong breakout signal. Short-term pattern data also points to weak follow-through over the next month.
["Q1 2026 buyout realizations exceeded $12 billion, showing strong monetization activity.", "The company attracted $13 billion in new capital, a positive signal for fundraising momentum.", "Q4 2025 revenue rose 29.13% YoY to $1.197 billion.", "Q4 2025 net income rose 69.80% YoY and EPS rose 68.42% YoY, indicating strong bottom-line growth.", "Gross margin remained very high at 83.21%."]
["Q1 2026 non-GAAP EPS missed expectations by $0.03.", "The share price fell 3.52% in the regular session, showing immediate selling pressure.", "Analyst targets have recently been cut by several firms, signaling softer expectations.", "BofA carries an Underperform rating and warned the first half of 2026 looks challenging.", "East 72 Dynasty Trust exited its Carlyle position in Q1, which is a cautious sentiment signal.", "No recent congress trading data and no notable politician buying support were available."]
In the latest reported quarter available, Q4 2025, Carlyle showed strong growth: revenue increased to $1.197 billion, up 29.13% YoY; net income rose to $358.1 million, up 69.80% YoY; EPS increased to 0.96, up 68.42% YoY; and gross margin was 83.21%, essentially flat but still very strong. The latest earnings news for Q1 2026 was less clean because non-GAAP EPS of $0.89 missed expectations by $0.03, even though realizations and fundraising were strong.
Recent analyst sentiment is mixed and slightly cautious. JPMorgan lowered its target to $66 and kept Neutral. Morgan Stanley cut its target to $66 and kept Equal Weight. Evercore raised target to $56 but kept In Line. TD Cowen still has a Buy rating but lowered its target to $55. Barclays remains Overweight but trimmed target to $67, while BofA is bearish at Underperform with a $48 target. Overall, Wall Street sees some upside potential, but the consensus is clearly not a strong bullish conviction; the pros point to fundraising momentum, margin expansion, and improving execution, while the cons center on challenged first-half conditions, lower realization expectations, and macro uncertainty.
